Osaic Holdings
VRDN icon

Osaic Holdings’s Viridian Therapeutics VRDN Stock Holding History

Osaic Holdings’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Buy
3,338
+2,508
+302% +$40.4K ﹤0.01% 5329
2026
Q1 		$16.2K Buy
830
+49
+6% +$1.46K ﹤0.01% 5993
2025
Q4 		$24.3K Buy
781
+26
+3% +$713 ﹤0.01% 5744
2025
Q3 		$16.3K Buy
755
+27
+4% +$487 ﹤0.01% 6067
2025
Q2 		$10.2K Buy
728
+516
+243% +$7K ﹤0.01% 6133
2025
Q1 		$2.86K Sell
212
-414
-66% -$7.05K ﹤0.01% 6454
2024
Q4 		$12K Buy
626
+10
+2% +$217 ﹤0.01% 5668
2024
Q3 		$14K Sell
616
-114
-16% -$1.86K ﹤0.01% 5596
2024
Q2 		$9.5K Buy
730
+91
+14% +$1.26K ﹤0.01% 5828
2024
Q1 		$11.2K Buy
639
+456
+249% +$8.84K ﹤0.01% 5692
2023
Q4 		$3.98K Sell
183
-857
-82% -$13.5K ﹤0.01% 6255
2023
Q3 		$16K Sell
1,040
-205
-16% -$3.91K ﹤0.01% 5668
2023
Q2 		$29.6K Buy
1,245
+32
+3% +$821 ﹤0.01% 5297
2023
Q1 		$30.9K Buy
1,213
+234
+24% +$7.5K ﹤0.01% 5301
2022
Q4 		$29K Buy
979
+58
+6% +$1.34K ﹤0.01% 5319
2022
Q3 		$18K Buy
+921
New +$16.6K ﹤0.01% 5665
2021
Q2 		– Sell
-950
Closed -$16K – 7141
2021
Q1 		$16K Buy
950
+870
+1,088% +$16.3K ﹤0.01% 5631
2020
Q4 		$1K Buy
+80
New +$1.21K ﹤0.01% 6286

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Osaic Holdings's VRDN Position: Q2 2026 in Review

Osaic Holdings increased its Viridian Therapeutics (VRDN) stake by 302% in Q2 2026, buying an estimated $40.4K and bringing the position to 3,338 shares worth $61.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5329.

Osaic Holdings first reported a position in VRDN in Q4 2020 and has held it in 18 quarters since. 212 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • Osaic Holdings held 3,338 shares of Viridian Therapeutics worth $61.3K as of Q2 2026.
  • Osaic Holdings bought 2,508 Viridian Therapeutics shares in Q2 2026, an estimated $40.4K.
  • Viridian Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5329 holding.
  • Osaic Holdings first reported a position in Viridian Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • 212 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.